List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 26 studies with search of:   Open Studies | "Neurofibromatoses"
Include studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Sirolimus in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas That Cannot Be Removed By Surgery
Conditions: Neurofibromatosis Type 1 (nf1);   Precancerous/Nonmalignant Condition
Intervention: Drug: sirolimus
2 Recruiting AZD2171 in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibroma and/or Neurofibroma Near the Spine
Conditions: Neurofibromatosis Type 1 (nf1);   Precancerous/Nonmalignant Condition
Intervention: Drug: cediranib maleate
3 Recruiting PEG-Interferon Alfa-2b in Treating Young Patients With Unresectable Plexiform Neurofibromas Associated With Neurofibromatosis Type 1
Conditions: Neurofibromatosis Type 1 (nf1);   Precancerous/Nonmalignant Condition
Intervention: Drug: PEG-interferon alfa-2b
4 Recruiting Sorafenib in Treating Young Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas That Cannot Be Removed by Surgery
Conditions: Neurofibromatosis Type 1 (nf1);   Precancerous/Nonmalignant Condition
Intervention: Drug: sorafenib tosylate
5 Recruiting Sunitinib in Treating Patients With Recurrent or Unresectable Meningioma, Intracranial Hemangiopericytoma, or Intracranial Hemangioblastoma
Conditions: Brain and Central Nervous System Tumors;   Neurofibromatosis Type 1 (nf1);   Neurofibromatosis Type 2 (nf2);   Precancerous/Nonmalignant Condition
Intervention: Drug: sunitinib malate
6 Recruiting Neurofibromatosis Type 1 (NF1) and Tibial Dysplasia
Conditions: Neurofibromatosis Type 1;   Tibial Dysplasia
Intervention:
7 Recruiting Trial to Evaluate the Safety of Lovastatin in Adults With Neurofibromatosis Type I (NF1)
Condition: Neurofibromatosis 1
Intervention: Drug: Lovastatin
8 Recruiting Multi-Center Project: Spinal Abnormalities in Neurofibromatosis Type1 (NF1) Patients
Condition: Neurofibromatosis Type 1
Intervention:
9 Recruiting Study of Disease Severity in Adults With Neurofibromatosis Type 1 (NF1)
Condition: Neurofibromatosis Type I
Intervention:
10 Recruiting Combination Chemotherapy in Treating Patients With Neurofibromatosis and Progressive Plexiform Neurofibromas
Conditions: Neurofibromatosis Type 1 (nf1);   Precancerous/Nonmalignant Condition
Interventions: Drug: methotrexate;   Drug: vinblastine
11 Recruiting Fludeoxyglucose F 18 Positron Emission Tomography and Magnetic Resonance Perfusion Imaging in Patients With Neurofibromatosis 1 and Plexiform Neurofibroma
Conditions: Neurofibromatosis Type 1 (nf1);   Precancerous/Nonmalignant Condition
Interventions: Drug: fludeoxyglucose F 18;   Drug: gadopentetate dimeglumine;   Procedure: magnetic resonance imaging;   Procedure: positron emission tomography;   Procedure: radionuclide imaging
12 Recruiting Combination Chemotherapy in Treating Patients With Stage III or Stage IV Malignant Peripheral Nerve Sheath Tumors
Conditions: Neurofibromatosis Type 1 (nf1);   Sarcoma
Interventions: Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: filgrastim;   Drug: ifosfamide;   Procedure: conventional surgery;   Procedure: radiation therapy
13 Recruiting Neurobiology and Treatment of Reading Disability in NF-1
Conditions: Neurofibromatosis Type 1;   Reading Disabilities
Interventions: Behavioral: Tutoring Program I;   Behavioral: Tutoring Program II
14 Recruiting NF1-Attention: Study of Children With Neurofibromatosis Type 1 Treated by Methylphenidate
Condition: Neurofibromatosis Type 1
Intervention: Drug: methylphenidate
15 Recruiting Quality of Friendships in Children With Neurofibromatosis
Condition: Neurofibromatosis
Intervention: Behavioral: Questionnaire
16 Recruiting Natural History and Biology of Skin Neurofibromas in Neurofibromatosis Type 1
Conditions: Dermal Neurofibromas;   Neurofibromatosis Type 1
Intervention:
17 Recruiting Ranibizumab for Neurofibromas Associated With Neurofibromatosis 1
Conditions: Neurofibromatosis Type 1;   Cutaneous Neurofibromas
Intervention: Drug: Ranibizumab
18 Recruiting A Phase II Study of the mTOR Inhibitor Sirolimus in Neurofibromatosis Type 1 Related Plexiform Neurofibromas
Condition: Neurofibromatosis Type 1
Intervention: Drug: Sirolimus, Rapamycin
19 Recruiting Collecting and Storing Information From Patients With Cancer or Other Chronic Disease Who Have Undergone Neurobehavioral Assessments on Another Clinical Trial
Conditions: Brain and Central Nervous System Tumors;   Cancer-Related Problem/Condition;   Leukemia;   Lymphoma;   Neurofibromatosis Type 1 (nf1);   Unspecified Adult Solid Tumor, Protocol Specific;   Unspecified Childhood Solid Tumor, Protocol Specific
Interventions: Procedure: cognitive assessment;   Procedure: management of therapy complications;   Procedure: physiologic testing;   Procedure: psychosocial assessment and care;   Procedure: quality-of-life assessment
20 Recruiting Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma
Conditions: CNS Cancer;   Meningioma;   Intracranial Hemangiopericytoma;   Hemangioblastoma;   Neurofibromatosis
Intervention: Drug: Sunitinib

Previous Page Studies Shown (1-20) Next (21-26)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services